(PFE/HSP)—S&P pharma analyst, Jeffrey Loo must be pretty sharp—he just upgraded HSP from Strong Sell to Hold: http://blogs.barrons.com/stockstowatchtoday/2015/02/05/pfizer-climbs-on-hospira-acquisition LMAO